Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer.

MLA

Søe, Kent, et al. “Dosing Related Effects of Zoledronic Acid on Bone Markers and Creatinine Clearance in Patients with Multiple Myeloma and Metastatic Breast Cancer.” Acta Oncologica (Stockholm, Sweden), vol. 53, no. 4, Apr. 2014, pp. 547–56. EBSCOhost, https://doi.org/10.3109/0284186X.2013.844358.

APA

Søe, K., Delaissé, J.-M., Jakobsen, E. H., Hansen, C. T., & Plesner, T. (2014). Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer. Acta Oncologica (Stockholm, Sweden), 53(4), 547–556. https://doi.org/10.3109/0284186X.2013.844358

Chicago

Søe, Kent, Jean-Marie Delaissé, Erik H Jakobsen, Charlotte T Hansen, and Torben Plesner. 2014. “Dosing Related Effects of Zoledronic Acid on Bone Markers and Creatinine Clearance in Patients with Multiple Myeloma and Metastatic Breast Cancer.” Acta Oncologica (Stockholm, Sweden) 53 (4): 547–56. doi:10.3109/0284186X.2013.844358.